Disease awareness campaign websites often encouraged rather than just described tests and treatments, highlighted benefit more than harm, and rarely noted potential problems such as overdiagnosis or overtreatment. https://ja.ma/3YTmpEi
JAMA
Book and Periodical Publishing
Chicago, Illinois 155,974 followers
JAMA is an international peer-reviewed general medical journal published online daily and in print weekly.
About us
JAMA, published continuously since 1883, is an international peer-reviewed general medical journal. JAMA is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications. JAMA is the most widely circulated general medical journal in the world, with more than 289,000 recipients of the print journal, more than 1.5 million recipients of electronic tables of contents and alerts, and over 30 million annual visits to the journal's website. JAMA is published 48 times per year in print/online issues, and new articles are published several times a week online. Without any author fees, all research articles are made free access online 6 months after publication on the JAMA website. In addition, the online version is freely available or nearly so to institutions in developing countries through the World Health Organization's HINARI program. Kirsten Bibbins-Domingo, PhD, MD, MAS, is the Editor in Chief of JAMA,. JAMA is a member of the International Committee of Medical Journal Editors, cosponsors the International Congress on Peer Review and Biomedical Publication, and is a member of the African Journal Partnership Project and is partnered with the Malawi Medical Journal. JAMA's key objective is to promote the science and art of medicine and the betterment of the public health. JAMA ISSN 0098-7484 (Print) ISSN 1538-3598 (Online)
- Website
-
http://ja.ma/JAMA
External link for JAMA
- Industry
- Book and Periodical Publishing
- Company size
- 1,001-5,000 employees
- Headquarters
- Chicago, Illinois
- Type
- Nonprofit
- Founded
- 1883
- Specialties
- Internal Medicine, Dermatology, Neurology, Surgery, Pediatrics, Ophthalmology, Otolaryngology, General Psychiatry, Cardiology, Oncology, Health Policy, Psychiatry, Surgery, Cardiology, Hypertension, Cholesterol, Diabetes, and Cancer
Locations
-
Primary
330 N Wabash Ave
Chicago, Illinois 60611, US
Employees at JAMA
-
Jennifer Abbasi
-
Nicholas Reback
MA, CMI | Medical Illustrator & Designer at the JAMA Network | Principal at Reback Biomedical Media
-
Paul G.
Vice President, Product Management and Development
-
Roy Perlis
Associate Chief (Research), Department of Psychiatry at Massachusetts General Hospital
Updates
-
Between 2009 and 2022, US adolescents reported declines in medical use and nonmedical use of prescription medications, concurring with other research. https://ja.ma/3Mf7pcu
-
JAMA Original Investigation: Elinzanetant significantly reduced vasomotor symptoms (VMS) frequency and severity in postmenopausal women. It also improved sleep disturbances and menopause-related quality of life with a favorable safety profile. #Menopause https://ja.ma/3AFeksP
-
This JAMA Patient Page defines obesity in adults and describes the health effects of obesity, the treatment options available, and the health benefits of weight loss. https://ja.ma/46TqtpX
-
JAMA Clinical Guidelines Synopsis summarizes the 2023 American Heart Association (AHA)/American College of Cardiology (ACC) guideline on management of patients with chronic coronary disease. https://ja.ma/3XaonPe
-
Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medications in conjunction with lifestyle modification according to their mechanism of action. https://ja.ma/3McJTwx
-
Most viewed in the last 7 days from JAMA: Narrative review investigates the use of direct oral anticoagulants to treat patients undergoing surgical and nonsurgical procedures and the most effective management strategies for these medications. https://ja.ma/3X1zGrV
-
Author JoAnn Pinkerton and JAMA Deputy Editor Linda Brubaker discuss the efficacy and safety of elinzanetant for the treatment of moderate to severe vasomotor symptoms associated with menopause. https://ja.ma/3yGA7jl
-
This Medical News article discusses terbinafine-resistant tinea, or ringworm, caused by the recently identified fungal species Trichophyton indotineae. https://ja.ma/4cCVHmv
-
Ivonescimab plus chemotherapy improved progression-free survival in patients with non-small cell lung cancer who progressed on treatment with EGFR-TKIs. #ASCO24 https://ja.ma/4csxkba